US regulators reject Sanofi's MS treatment Lemtrada
December 30, 2013 at 07:23 AM EST
Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme.